Journal
Crohns & Colitis 360
Publication Date
10-1-2026
Volume
8
Issue
4
First Page
otag086
Document Type
Open Access Publication
DOI
10.1093/crocol/otag086
Rights and Permissions
Youssef Hafez, Ali Osman, Wing-Kin Syn, Manar Shmais, Comparative effectiveness of IL-12/23 and IL-23 inhibitors versus JAK inhibitors in patients with inflammatory bowel disease and hidradenitis suppurativa: a real-world propensity-matched analysis, Crohn's & Colitis 360, Volume 8, Issue 4, October 2026, otag086, https://doi.org/10.1093/crocol/otag086. https://academic.oup.com/crohnscolitis360/article/8/4/otag086/9006044?login=true. © The Author(s) 2026. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected].
Recommended Citation
Hafez, Youssef; Osman, Ali; Syn, Wing-Kin; and Shmais, Manar, "Comparative effectiveness of IL-12/23 and IL-23 inhibitors versus JAK inhibitors in patients with inflammatory bowel disease and hidradenitis suppurativa: A real-world propensity-matched analysis." Crohns & Colitis 360. 8, 4. otag086 (2026).
https://digitalcommons.wustl.edu/oa_4/7785
Additional Links
Supplemental material is available for this article at publisher site.
